查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1430043

胰岛素输送设备市场规模：按类型、最终用户划分 - 区域展望、竞争策略、细分市场预测（~2033 年）

Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 224 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2033年，胰岛素输送设备市场规模预计将成长至701.4亿美元，预测期内复合年增长率为8.71%。

胰岛素输送设备市场受到 COVID-19 爆发的严重影响。 I 型糖尿病患者受 COVID-19 的影响更大。由于您的免疫系统已经被削弱，接触 COVID-19 会使您的病情迅速恶化。他们也可能比健康人更容易出现严重併发症。

本报告调查了全球胰岛素输送设备市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争形势以及主要企业。总结的。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

  • 驱动因素、限制因素、机会与挑战分析
  • COVID-19 对市场的影响

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争形势

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第七章胰岛素输送设备市场：依类型

  • 全球市占率及预测
  • 胰岛素笔针
  • 胰岛素帮浦
  • 胰岛素注射器
  • 胰岛素笔针针

第八章胰岛素输送设备市场：依最终用户分类

  • 全球市占率及预测
  • 医院/诊所
  • 病人/居家照护

第九章胰岛素输送装置市场预测

  • 市场规模/市场占有率

第10章胰岛素输送设备市场：依类型

  • 市场规模/市场占有率趋势/预测

第十一章胰岛素输送设备市场：依最终用户分类

  • 市场规模/市场占有率趋势/预测

第十二章胰岛素输送设备市场：按地区

  • 市场规模/市场占有率趋势/预测
  • 东
  • 西
  • 北方
  • 南部

第十三章 公司简介

  • Biocon Limited
  • Diabetes Care Business
  • Eli Lilly and Company
  • Hindustan Syringes & Medical Devices Ltd.
  • Insulet Corporation
  • Mannkind Corporation
  • Sanofi
  • Terumo Corporation
  • Vicentra BV
  • Others

第 14 章简称表

第十五章 参考链接

第16章结论

第十七章 研究范围

简介目录
Product Code: HLCA2417

Insulin Delivery Devices Market Introduction and Overview

According to SPER market research, 'Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Insulin Delivery Devices Market is predicted to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.

The beta cells in the islets of Langerhans of the pancreas produce the hormone insulin. By promoting cellular glucose uptake and controlling the metabolism of fats, proteins, and carbohydrates, the hormone keeps blood glucose levels within normal ranges. Type I and type II diabetes can be brought on by inappropriate insulin function brought on by damaged beta cells or the body's incapacity to utilize the insulin that is produced.

Furthermore, the market for insulin delivery devices was significantly impacted by the COVID-19 pandemic. Patients with type 1 diabetes are more affected by COVID-19. Due to their already compromised immune systems, people with diabetes quickly deteriorate when exposed to COVID-19. Individuals with diabetes may be more susceptible than healthy individuals to major complications.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.

Insulin Delivery Devices Market Segmentation:

By Type: Based on the Method type, Insulin Delivery Devices Market is segmented as; Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standards & Safety).

By End User: Based on the End User, Insulin Delivery Devices Market is segmented as; (Hospitals & Clinics, Patients & Homecare).

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Insulin Delivery Devices Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices Market

7. Insulin Delivery Devices Market, By Type (USD Million)

  • 7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Insulin Pens
  • 7.3. Insulins Pumps
  • 7.4. Insulin Syringes
  • 7.5. Insulin Pen Needles

8. Insulin Delivery Devices Market, By End User (USD Million)

  • 8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
  • 8.2. Hospitals & Clinics
  • 8.3. Patients & Homecare

9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)

  • 9.1. Insulin Delivery Devices Market Size and Market Share

10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)

  • 10.1. Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
  • 10.2. Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)

11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)

  • 11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
  • 11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)

12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)

  • 12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
  • 12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
  • 12.3. Eastern Region
  • 12.4. Western Region
  • 12.5. Northern Region
  • 12.6. Southern Region

13. Company Profile

  • 13.1. Biocon Limited
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Diabetes Care Business
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Eli Lilly and Company
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Hindustan Syringes & Medical Devices Ltd.
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Insulet Corporation
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. Mannkind Corporation
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Sanofi
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Terumo Corporation
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. Vicentra B.V.
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope